A federal judge has rejected health insurer Aetna's bid to buy rival Humana on grounds that the deal would hurt competition in hundreds of Medicare Advantage markets, ultimately affecting the price consumers pay for coverage.
Jan 23, 2017
0
0
The pharmaceuticals sector is facing an intensive period of mergers and acquisitions in the coming years, even if US firms Pfizer and Allergan recently failed to tie the knot, the corporate consultancy firm EY said Monday.
May 30, 2016
0
3
The American College of Physicians (ACP) today told the U.S. Department of Justice Antitrust Division that it has "significant concerns about the pending mergers between Aetna/Humana and Anthem/Cigna and the potential negative ...
Dec 3, 2015
0
3
In a big year for deal making, the health care industry is a standout. Large drugmakers are buying and selling businesses to control costs and deploy surplus cash. A rising stock market, tax strategies and low interest rates ...
Nov 23, 2014
0
0
Shares of the Indian units of US pharmaceutical firms Pfizer and Wyeth soared Monday, after the pair approved a merger plan which would create India's ninth largest drug company.
Nov 25, 2013
0
0
Competition from generic drugs continued to hammer French pharmaceutical group Sanofi in the second quarter, the company said Thursday, warning that its full-year earnings could be twice as bad as previous guidance.
Aug 1, 2013
0
0
